Abstract
Opioid receptors involved in regulating the motility of the gastrointestinal tract have been localized in both contractile and neuronal tissues. Trimebutine, a peripheral opioid receptor agonist, modulates gastrointestinal motor activity in both directions and also may act on cardiac tissue. This study investigated the effects of trimebutine in clinical doses on cardiac autonomic functions with heart rate variability. The effect of trimebutine on cardiac autonomic outflows was evaluated in 11 healthy subjects. Trimebutine (200 mg) or placebo was administered orally at random in a double-blind, cross-over manner. Continuous electrocardiography recordings were obtained before and after drug administration during three states: rest, controlled breathing, and a hand grip exercise. Heart rate variability analysis showed that there was no significant difference between subjects administered with placebo or trimebutine throughout rest, controlled breathing, or the hand grip exercise. We concluded that trimebutine, in clinical doses, has no significant effect on cardiac autonomic functions.
Similar content being viewed by others
References
Boehm S, Kubista H (2002) Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors. Pharmacol Rev 54:43–99
Caffrey JL, Mateo Z, Napier LD, Gaugl JF, Barron B (1995) Intrinsic cardiac enkephalins inhibit vagal bradycardia in the dog. Am J Physiol 268:H848–H855
Delvaux M, Wingate D (1997) Trimebutine: mechanism of action, effects on gastrointestinal function and clinical results. J Int Med Res 25:225–246
Diop L, Pascaud X, Le Gallou B, Junien JL (1992) Travel stress alters the intestinal migrating myoelectric complex in rats: antagonist effect of trimebutine. Life Sci 50:263–271
Drolet B, Rousseau G, Daleau P, Cardinal R, Turgeon J (2000) Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation 102:1883–1885
Ellidokuz E, Kaya D (2003) The effect of metoclopramide on QT dynamicity: double-blind, placebo-controlled, cross-over study in healthy male volunteers. Aliment Pharmacol Ther 18:151–155
Hung CF, Chang WL, Liang HC, Su MJ (2000) Identification of opioid receptors in the sympathetic and parasympathetic nerves of guinea-pig atria. Fundam Clin Pharmacol 14:387–394
Igawa O, Kotake H, Hirai S, Hisatome I, Hasegawa J, Mashiba H (1989) Effects of trimebutine maleate on electrical activities of isolated mammalian cardiac preparations. J Pharm Pharmacol 41:311–315
Jhee OH, Lee YS, Shaw LM, Jeon YC, Lee MH, Lee SH, Kang JS (2007) Pharmacokinetic and bioequivalence evaluation of two formulations of 100 mg trimebutine maleate (Recutin™ and Polybutin™) in healthy male volunteers using the LC–MS/MS method. Clin Chim Acta 375:69–75
Kamath MV, Fallen EL (1993) Power spectral analysis of heart ate variability: a noninvasive signature of cardiac autonomic function. Crit Rev Biomed Eng 21:245–311
Kaya D, Ellidokuz E, Onrat E, Ellidokuz H, Celik A, Kilit C (2003) The effect of dopamine type-2 receptor blockade on autonomic modulation. Clin Auton Res 13:275–280
Lacheze C, Coelho AM, Fioramonti J, Bueno L (1998) Influence of trimebutine on inflammation- and stress-induced hyperalgesia to rectal distension in rats. J Pharm Pharmacol 50:921–928
Mannelli M, Ianni L, Lazzeri C, Castellani W, Pupilli C, La Villa G, Barletta G, Serio M, Franchi F (1999) In vivo evidence that endogenous dopamine modulates sympathetic activity in man. Hypertension 34:398–402
Morisawa T, Hasegawa J, Tanabe K, Watanabe A, Kitano M, Kishimoto Y (2000) Effects of trimebutine maleate on delayed rectifier K+ currents in guinea-pig ventricular myocytes. J Pharm Pharmacol 52:403–408
Nagasaki M, Komori S, Ohashi H (1993) Effect of trimebutine on voltage-activated calcium current in rabbit ileal smooth muscle cells. Br J Pharmacol 110:399–403
Okano H, Saeki S, Inui A, Kawai Y, Ohno S, Morimoto S, Ohmoto A, Nakashima T, Miyamoto M, Okita M, et al (1993) Effect of trimebutine maleate on emptying of stomach and gallbladder and release of gut peptide following a solid meal in man. Dig Dis Sci 38:817–823
Pugsley MK, Saint DA, Hayes E, Kramer D, Walker MJA (1998) The sodium channel blocking properties of spiradoline, a κ-receptor agonist, are responsible for its antiarrhythmic action in the rat. J Cardiovasc Pharmacol 32:863–874
Pugsley MK, Saint DA, Penz WP, Walker MJA (1993) Electrophysiological and antiarrhythmic actions of the kappa agonist PD129290, and its R,R (+) enantiomer. PD 129289. Br J Pharmacol 110:1579–1585
Roman FJ, Lanet S, Hamon J, Brunelle G, Maurin A, Champeroux P, Richard S, Alessandri N, Gola M (1999) Pharmacological properties of trimebutine and N-monodesmethyltrimebutine. J Pharmacol Exp Ther 289:1391–1397
Schultz JE, Gross GJ (2001) Opioids and cardioprotection. Pharmacol Ther 89:123–137
Stendal C (1998) Practical guide to gastrointestinal function testing. Blackwell Scientific Publications Ltd, Milan
Taniyama K, Sano I, Nakayama S, Matsuyama S, Tadeka K, Yoshihara C, Tanaca C (1991) Dual effect of trimebutine on contractility of the guinea pig ileum via the opioid receptors. Gastroenterology 101:1579–1587
Task Force of the European Society of Cardiology, the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043–1065
Ventura C, Spurgeon H, Lakatta EG, Guarnieri C, Capogrossi MC (1992) κ and δ opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons. Circ Res 70:66–81
Wang SH, Lin CY, Huang TY, Wu WS, Chen CC, Tsai SH (2001) QT interval effects of cisapride in the clinical setting. Int J Cardiol 80:179–183
Wong TM, Shan J (2001) Modulation of sympathetic actions on the heart by opioid receptor stimulation. J Biomed Sci 8:299–306
Wysowski DK, Bacsanyi J (1996) Cisapride and fatal arrhythmia. N Engl J Med 335:290–291
Xiao RP, Pepe S, Spurgeon HA, Capogrossi MC, Lakatta EG (1997) Opioid peptide receptor stimulation reverses β adrenergic effects in rat heart cells. Am J Physiol 272:H797–H805
Zimlichman R, Gefel D, Eliahou H, Matas Z, Rosen B, Gass S, Ela C, Eilam Y, Vogel Z, Barg J (1996) Expression of opioid receptors during heart ontogeny in normotensive and hypertensive rats. Circulation 93:1020–1025
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ellidokuz, E., Kaya, D., Uslan, İ. et al. Activation of peripheral opioid receptors has no effect on heart rate variability. Clin Auton Res 18, 145–149 (2008). https://doi.org/10.1007/s10286-008-0469-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10286-008-0469-9